ES-481 May Reduce Seizures In Hard-To-Control Epilepsy
This study tested ES-481, a new add-on anti-seizure medicine, in adults with drug-resistant epilepsy.
This study tested ES-481, a new add-on anti-seizure medicine, in adults with drug-resistant epilepsy.
Researchers combined results from randomized, double-blind studies that tested two add-on seizure medicines, lacosamide (LCM) and brivaracetam (BRV), in adults and older teens with drug-resistant focal epilepsy.
This report describes one premature newborn boy in the Netherlands who had hard-to-control seizures.
This paper was a structured narrative review, not a new clinical trial.
This paper describes the Urgent Epileptic Seizures Care Process in the Community of Madrid for severe epileptic seizures, also called the “Seizure Code.” It is intended for both children and adults.
This paper combined results from earlier studies to look for factors linked with response to vagus nerve stimulation (VNS) in people with drug-resistant epilepsy.
This study analyzed medical records from 180 children with autism spectrum disorder (ASD) who were hospitalized at a pediatric neurology center in Katowice, Poland.
Researchers looked at whether checking the quality of pulse signals from a wearable light sensor, called photoplethysmography (PPG), could improve seizure detection.
This study was a systematic review and meta-analysis.